Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

R&D Call: Deucrictibant: Beyond HAE-1/2

Join Pharvaris for a virtual R&D call, titled “Deucrictibant: Beyond HAE Type 1/2". The virtual event will explore the pathophysiology…
TIME: 8:00 AM EDT
LOCATION: Virtual
View Details

Immix Biopharma Virtual KOL Event to Discuss NXC-201 NEXICART-2 Interim Trial Results Presented at ASCO in relapsed/refractory AL Amyloidosis

Join Immix Biopharma for a Virtual Key Opinion Leader (KOL) event to discuss interim trial results from the NEXICART-2 Phase…
TIME: 3:00 PM EDT
LOCATION: Virtual
View Details

Xeris Biopharma In-Person Analyst and Investor Day

Join Xeris Biopharma for an in-person and virtual analyst and investor day in New York featuring three key opinion leaders…
TIME: 10:00 AM EDT
LOCATION: Midtown NYC
View Details

Reviva Pharmaceuticals Virtual KOL Event to Discuss Full Data Set from 1-Year Open Label Extension Study of Brilaroxazine for the Treatment of Schizophrenia

Join Reviva Pharmaceuticals for a virtual key opinion leader (KOL) event featuring Stephen R. Marder, MD (UCLA Psychosis Clinic) and Larry Ereshefsky, PharmD,…
TIME: 8:00 AM EDT
LOCATION: Virtual
View Details

Actuate Therapeutics Investor Event at ASCO to Discuss Elraglusib Phase 2 Topline Data in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Join Actuate Therapeutics for an in-person and virtual investor event to review topline data from the Phase 2 (Actuate-1801 Part…
TIME: 6:30 PM CDT
LOCATION: Marriott Marquis Chicago, 2121 S Prairie Ave, Chicago, IL 60616
View Details

Sagimet Biosciences Virtual KOL Event: Evaluating the Synergistic Potential of a Combination of Denifanstat and Resmetirom for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Join Sagimet Biosciences for a virtual key opinion leader (KOL) event featuring Rohit Loomba, MD, MHSc (Professor of Medicine, Chief, Division…
TIME: 1:00 PM EDT
LOCATION: Virtual
View Details

BioVie Inc. Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease

Join BioVie Inc. for a virtual key opinion leader (KOL) event featuring Suzanne de la Monte, MD, MPH (Brown University…
TIME: 12:00 PM EDT
LOCATION: Virtual
View Details

Inmagene Biopharmaceuticals Virtual KOL Event to Discuss the Potential Role of Anti-OX40/OX40L Monoclonal Antibodies (mAbs) in the Treatment of Alopecia Areata (AA)

Join Inmagene Biopharmaceuticals for a virtual key opinion leader (KOL) event featuring Emma Guttman, MD, PhD (Icahn School of Medicine…
TIME: 11:00 AM EDT
LOCATION: Virtual
View Details

DiaMedica Therapeutics Virtual KOL Event to Discuss DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia

Join DiaMedica Therapeutics for a virtual key opinion leader (KOL) event featuring Dr. Baha M. Sibai, Professor (McGovern Medical School at UTHealth…
TIME: 8:00 AM EDT
LOCATION: Virtual
View Details

Cidara Therapeutics Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza

Join Cidara Therapeutics for a virtual R&D Day featuring key opinion leaders (KOLs) Fred Hayden, MD, FACP (University of Virginia…
TIME: 10:00 AM EDT
LOCATION: Virtual
View Details

Mobilizing the Immune System: Cue Biopharma’s Novel Biologics Portfolio Event

Join Cue Biopharma (CUE) for a virtual event featuring two key opinion leaders (KOLs) Richard DiPaolo, PhD (Saint Louis University) and Andrew Cope,…
TIME: 11:00 AM EDT
LOCATION: Virtual
View Details

Atea Pharmaceuticals Virtual KOL Event to Discuss the Current Challenges for Patients with Hepatitis C, Results from Atea’s Phase 2 Study of the regimen of Bemnifosbuvir and Ruzasvir, and What a New Optimized HCV Therapy Could Provide for Prescribers and Patients

Join Atea Pharmaceuticals for a virtual panel discussion featuring several key opinion leaders (KOLs) including: Eric Lawitz, MD - Texas Liver…
TIME: 10:00 AM EDT
LOCATION: Virtual
View Details

Eupraxia Pharmaceuticals Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE)

Join Eupraxia Pharmaceuticals for a virtual KOL event featuring key opinion leader (KOL) Evan Dellon, MD, MPH (University of North Carolina,…
TIME: 9:00 AM EDT
LOCATION: Virtual
View Details

BioVersys AG Virtual KOL Event: BV100 Shows Survival Benefit in Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter. What Does that Mean for Patients? A Perspective from the US and from Asia.

Join BioVersys for a virtual key opinion leader (KOL) event featuring Professor David Paterson (ADVANCE-ID, Saw Swee Hock School of…
TIME: 8:30 AM EDT
LOCATION: Virtual
View Details

Theriva™ Biologics VIRAGE Phase 2b Pancreatic Cancer Clinical Trial of VCN-01 Top line Data Update

Details to follow.
TIME: 8:00 AM EDT
LOCATION: Virtual
View Details

Praxis Precision Medicines virtual investor event to discuss clinical programs in Developmental and Epileptic Encephalopathies (DEEs)

Join Praxis Precision Medicines for a virtual investor event hosted by company management, who will focus on their DEE clinical…
TIME: 10:00 AM EDT
LOCATION: Virtual
View Details